The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...

The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary - Cancer rates are rising everywhere ...

Panelists discuss how comprehensive patient education about expected adverse effects, combined with prophylactic measures ...